• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于骨钙素启动子的毒性基因疗法在实验模型中治疗骨肉瘤

Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.

作者信息

Ko S C, Cheon J, Kao C, Gotoh A, Shirakawa T, Sikes R A, Karsenty G, Chung L W

机构信息

Molecular Urology and Therapeutics Program, Department of Urology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.

出版信息

Cancer Res. 1996 Oct 15;56(20):4614-9.

PMID:8840973
Abstract

Osteocalcin (OC), a noncollagenous bone matrix protein, is expressed in high levels by osteoblasts. To determine whether the OC promoter mediates cell-specific gene expression in cells of osteoblast lineage, we constructed a recombinant adenovirus, Ad-OC-TK, which contains the OC promoter that drives the expression of herpes simplex virus thymidine kinase (TK). We tested the expression of TK by this virus in osteoblast cell lines as well as in non-osteoblastic cell lines by assessing the enzyme activity of TK in vitro. Whereas the OC promoter failed to drive the expression of the TK gene in several non-osteoblastic cell lines such as WH, a human bladder transitional carcinoma, and NIH 3T3, an embryonic mouse fibroblast cell line, the OC promoter mediated high levels of expression in osteoblast cell lines including murine ROS and human MG-63 cells. The addition of acyclovir (ACV), a pro-drug for the inhibition of cell proliferation, resulted in the induction of osteoblast-specific cell death in vitro. Intratumoral injection of Ad-OC-TK into murine ROS osteosarcoma abolished tumor growth in a host treated with subsequent i.p. ACV injection in vivo. The Ad-OC-TK virus plus ACV treatment appears to be highly selective in blocking the growth of both murine and human osteosarcoma cell lines in vitro and murine osteosarcoma in vivo.

摘要

骨钙素(OC)是一种非胶原蛋白骨基质蛋白,由成骨细胞高水平表达。为了确定OC启动子是否介导成骨细胞谱系细胞中的细胞特异性基因表达,我们构建了一种重组腺病毒Ad-OC-TK,其包含驱动单纯疱疹病毒胸苷激酶(TK)表达的OC启动子。我们通过在体外评估TK的酶活性,测试了该病毒在成骨细胞系以及非成骨细胞系中TK的表达。虽然OC启动子未能在几种非成骨细胞系中驱动TK基因的表达,如人膀胱移行癌WH和胚胎小鼠成纤维细胞系NIH 3T3,但OC启动子在包括小鼠ROS和人MG-63细胞在内的成骨细胞系中介导了高水平的表达。添加阿昔洛韦(ACV),一种用于抑制细胞增殖的前体药物,导致体外成骨细胞特异性细胞死亡的诱导。将Ad-OC-TK瘤内注射到小鼠ROS骨肉瘤中,在随后腹腔注射ACV治疗的宿主体内消除了肿瘤生长。Ad-OC-TK病毒加ACV治疗在体外阻断小鼠和人骨肉瘤细胞系的生长以及在体内阻断小鼠骨肉瘤的生长方面似乎具有高度选择性。

相似文献

1
Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models.基于骨钙素启动子的毒性基因疗法在实验模型中治疗骨肉瘤
Cancer Res. 1996 Oct 15;56(20):4614-9.
2
Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.化学基因疗法:基于骨钙素启动子的自杀基因疗法联合甲氨蝶呤在小鼠骨肉瘤模型中的应用
Cancer Gene Ther. 1997 Nov-Dec;4(6):359-65.
3
In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy.基于静脉注射骨钙素启动子的毒性基因疗法对骨肉瘤肺转移的体内抑制作用
Cancer Gene Ther. 1998 Sep-Oct;5(5):274-80.
4
Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.在一种涉及人前列腺癌和骨基质细胞生长的新型嵌合肿瘤模型中对肿瘤和基质进行共靶向。
Cancer Gene Ther. 2004 Feb;11(2):148-55. doi: 10.1038/sj.cgt.7700665.
5
Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.一种具有转录复制能力的腺病毒Ad-OC-E1a对骨肉瘤肺转移的抗肿瘤疗效。
J Gene Med. 2006 Jun;8(6):679-89. doi: 10.1002/jgm.904.
6
The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.端粒酶逆转录酶启动子驱动有效的肿瘤自杀基因治疗,同时防止组成型启动子所导致的肝毒性。
Gene Ther. 2001 Apr;8(7):568-78. doi: 10.1038/sj.gt.3301421.
7
Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.用表达单纯疱疹病毒胸苷激酶的复制型腺病毒载体治疗恶性胶质瘤。
Cancer Res. 2001 Dec 15;61(24):8743-50.
8
Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.Cre重组酶/loxP系统的应用进一步增强了针对产生癌胚抗原的癌症的细胞类型特异性基因治疗中的抗肿瘤效果。
Cancer Res. 1999 Oct 1;59(19):4906-11.
9
Human prostate cancer progression models and therapeutic intervention.人类前列腺癌进展模型与治疗干预
Hinyokika Kiyo. 1997 Nov;43(11):815-20.
10
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.腺病毒介导的增强型单纯疱疹病毒胸苷激酶突变体基因转移可改善前体药物介导的肿瘤细胞杀伤作用。
Cancer Gene Ther. 2003 May;10(5):353-64. doi: 10.1038/sj.cgt.7700589.

引用本文的文献

1
Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics.前列腺癌骨转移和内脏器官转移的肿瘤微环境中的调控信号网络及新型疗法的开发。
Asian J Urol. 2019 Jan;6(1):65-81. doi: 10.1016/j.ajur.2018.11.003. Epub 2018 Nov 28.
2
Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.通过人骨连接蛋白启动子介导的自杀基因疗法共靶向前列腺癌上皮和骨基质可有效抑制雄激素非依赖性前列腺癌生长。
PLoS One. 2016 Apr 7;11(4):e0153350. doi: 10.1371/journal.pone.0153350. eCollection 2016.
3
Gene delivery in a mouse xenograft of a retargeted retrovirus to a solid 143B osteosarcoma.
重定向逆转录病毒在 143B 骨肉瘤小鼠异种移植中的基因传递。
Virol J. 2013 Jun 14;10:194. doi: 10.1186/1743-422X-10-194.
4
Genetically engineered mouse models and human osteosarcoma.基因工程小鼠模型与人类骨肉瘤
Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19.
5
Potent growth-inhibitory effect of TRAIL therapy mediated by double-regulated oncolytic adenovirus on osteosarcoma.双调控溶瘤腺病毒介导 TRAIL 治疗对骨肉瘤的强效生长抑制作用。
Mol Cell Biochem. 2012 May;364(1-2):337-44. doi: 10.1007/s11010-012-1235-9. Epub 2012 Feb 22.
6
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.使用M6启动子增强联合肿瘤特异性溶瘤和自杀基因疗法治疗前列腺癌
Cancer Gene Ther. 2009 Jan;16(1):73-82. doi: 10.1038/cgt.2008.59. Epub 2008 Sep 5.
7
Molecular approaches to sarcoma therapy.肉瘤治疗的分子方法。
Sarcoma. 2002;6(1):27-42. doi: 10.1080/13577140220127530.
8
BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.骨钙素在胰腺癌细胞中表达,并增加其生长和侵袭能力。
Mol Cancer. 2007 Dec 28;6:83. doi: 10.1186/1476-4598-6-83.
9
Transcriptional Targeting in Cancer Gene Therapy.癌症基因治疗中的转录靶向
J Biomed Biotechnol. 2003;2003(2):110-137. doi: 10.1155/S1110724303209074.
10
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.骨髓细胞移植后成骨细胞特异性基因表达:对骨骼基因治疗的启示
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7294-9. doi: 10.1073/pnas.96.13.7294.